1. Home
  2. LGVN vs GDHG Comparison

LGVN vs GDHG Comparison

Compare LGVN & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • GDHG
  • Stock Information
  • Founded
  • LGVN 2014
  • GDHG 2008
  • Country
  • LGVN United States
  • GDHG China
  • Employees
  • LGVN N/A
  • GDHG N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • LGVN Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • LGVN 7.8M
  • GDHG 8.5M
  • IPO Year
  • LGVN 2021
  • GDHG 2023
  • Fundamental
  • Price
  • LGVN $4.37
  • GDHG $0.18
  • Analyst Decision
  • LGVN Strong Buy
  • GDHG
  • Analyst Count
  • LGVN 1
  • GDHG 0
  • Target Price
  • LGVN $12.00
  • GDHG N/A
  • AVG Volume (30 Days)
  • LGVN 27.4M
  • GDHG 16.5M
  • Earning Date
  • LGVN 08-09-2024
  • GDHG 08-01-2024
  • Dividend Yield
  • LGVN N/A
  • GDHG N/A
  • EPS Growth
  • LGVN N/A
  • GDHG N/A
  • EPS
  • LGVN N/A
  • GDHG 0.13
  • Revenue
  • LGVN $978,000.00
  • GDHG $31,786,802.00
  • Revenue This Year
  • LGVN $137.24
  • GDHG N/A
  • Revenue Next Year
  • LGVN $50.77
  • GDHG N/A
  • P/E Ratio
  • LGVN N/A
  • GDHG $1.41
  • Revenue Growth
  • LGVN N/A
  • GDHG N/A
  • 52 Week Low
  • LGVN $0.77
  • GDHG $0.15
  • 52 Week High
  • LGVN $37.50
  • GDHG $24.99
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 68.96
  • GDHG 46.37
  • Support Level
  • LGVN $3.80
  • GDHG $0.17
  • Resistance Level
  • LGVN $6.40
  • GDHG $0.21
  • Average True Range (ATR)
  • LGVN 0.50
  • GDHG 0.02
  • MACD
  • LGVN 0.25
  • GDHG 0.01
  • Stochastic Oscillator
  • LGVN 49.76
  • GDHG 55.23

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: